GlassScriptPhysician profile
Ann R Kooken
NPI 1043315666
$13,235.11
in general payments reported to CMS, 2019-2025
49 companies · $1,773 in 2025
The $1,773 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,988 · 2020: $723 · 2021: $1,560 · 2022: $2,082 · 2023: $2,444 · 2024: $2,666 · 2025: $1,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,703 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,703.49 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,099.33 | 2019-2025 | |
| Lilly USA, LLC | $1,289.41 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $1,196.40 | 2019-2025 | Winlevi, Absorica Ld, Ilumya |
| Leo Pharma INC. | $806.27 | 2019-2025 | Adbry, Spevigo, Anzupgo |
| Janssen Biotech, INC. | $787.18 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $646.69 | 2019-2025 | |
| Ucb, INC. | $638.40 | 2020-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $455.60 | 2019-2025 | Aklief, Epsolay, Oracea |
| Genzyme Corporation | $454.13 | 2019-2024 | |
| Pfizer INC. | $398.61 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $370.73 | 2022-2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $356.51 | 2019-2025 | Jublia, Cabtreo, Siliq |
| Dermavant Sciences, INC. | $355.95 | 2022-2024 | Vtama |
| Amgen INC. | $340.53 | 2020-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $315.79 | 2019-2025 | Dupixent, Libtayo |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Kooken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.